User menu

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

Bibliographic reference Clancy, J P ; Rowe, Steven M ; Accurso, Frank J ; Aitken, Moira L ; Amin, Raouf S ; et. al. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. In: Thorax : an international journal of respiratory medicine, Vol. 67, no. 1, p. 12-88 (2012)
Permanent URL http://hdl.handle.net/2078.1/126386